123 related articles for article (PubMed ID: 27421003)
1. Correlation between polymorphisms in the visfatin gene and its expression in the serum and coronary artery calcification.
Jin LW; Zheng SB; Zhou ZH; Pan SF; Zheng Y
Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421003
[TBL] [Abstract][Full Text] [Related]
2. Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population.
Elahirad S; Elieh Ali Komi D; Kiani A; Mohammadi-Noori E; Vaisi-Raygani A; Mozafari H; Bahrehmand F; Saidi M; Toupchi-Khosroshahi V; Salehi N
Cardiovasc Toxicol; 2022 Feb; 22(2):118-129. PubMed ID: 34731407
[TBL] [Abstract][Full Text] [Related]
3. Accelerated cardiovascular risk after viral clearance in hepatitis C patients with the NAMPT-rs61330082 TT genotype: An 8-year prospective cohort study.
Chang ML; Lin YS; Chang MY; Hsu CL; Chien RN; Fann CS
Virulence; 2021 Dec; 12(1):270-280. PubMed ID: 33446046
[TBL] [Abstract][Full Text] [Related]
4. The Correlation of Visfatin and Its Gene Polymorphism with Non-Small Cell Lung Cancer.
Zhang LJ; Li XQ; Wang CD; Zhuang L; Gong Q; Li SJ; Liu X; Dong H; Wang XC
Cancer Biother Radiopharm; 2018 Dec; 33(10):460-465. PubMed ID: 30256660
[No Abstract] [Full Text] [Related]
5. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.
Jian WX; Luo TH; Gu YY; Zhang HL; Zheng S; Dai M; Han JF; Zhao Y; Li G; Luo M
Diabet Med; 2006 Sep; 23(9):967-73. PubMed ID: 16922702
[TBL] [Abstract][Full Text] [Related]
6. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients.
Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B
Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156
[TBL] [Abstract][Full Text] [Related]
7. The relationship between coronary calcification and the metabolic markers of osteopontin, fetuin-A, and visfatin.
Uz O; Kardeşoğlu E; Yiğiner O; Baş S; Ipçioğlu OM; Ozmen N; Aparci M; Cingözbay BY; Işilak Z; Cebeci BS
Turk Kardiyol Dern Ars; 2009 Sep; 37(6):397-402. PubMed ID: 20019453
[TBL] [Abstract][Full Text] [Related]
8. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
[TBL] [Abstract][Full Text] [Related]
9. The -1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects.
Tokunaga A; Miura A; Okauchi Y; Segawa K; Fukuhara A; Okita K; Takahashi M; Funahashi T; Miyagawa J; Shimomura I; Yamagata K
Endocr J; 2008 Mar; 55(1):205-12. PubMed ID: 18270432
[TBL] [Abstract][Full Text] [Related]
10. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
[TBL] [Abstract][Full Text] [Related]
11. A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease.
Wang LS; Yan JJ; Tang NP; Zhu J; Wang YS; Wang QM; Tang JJ; Wang MW; Jia EZ; Yang ZJ; Huang J
Mol Biol Rep; 2011 Feb; 38(2):819-25. PubMed ID: 20383745
[TBL] [Abstract][Full Text] [Related]
12. Low serum magnesium is associated with coronary artery calcification in a Korean population at low risk for cardiovascular disease.
Lee SY; Hyun YY; Lee KB; Kim H
Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):1056-61. PubMed ID: 26472514
[TBL] [Abstract][Full Text] [Related]
13. Association of Nicotinamide Phosphoribosyltransferase (NAMPT) Gene Polymorphisms and of Serum NAMPT Levels with Dilated Cardiomyopathy in a Chinese Population.
Dou Q; Peng Y; Zhou B; Zhang K; Lin J; Dai X; Zhang L; Rao L
Int J Mol Sci; 2015 Sep; 16(9):22299-318. PubMed ID: 26389889
[TBL] [Abstract][Full Text] [Related]
14. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
[TBL] [Abstract][Full Text] [Related]
15. Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort).
Ferguson JF; Matthews GJ; Townsend RR; Raj DS; Kanetsky PA; Budoff M; Fischer MJ; Rosas SE; Kanthety R; Rahman M; Master SR; Qasim A; Li M; Mehta NN; Shen H; Mitchell BD; O'Connell JR; Shuldiner AR; Ho WK; Young R; Rasheed A; Danesh J; He J; Kusek JW; Ojo AO; Flack J; Go AS; Gadegbeku CA; Wright JT; Saleheen D; Feldman HI; Rader DJ; Foulkes AS; Reilly MP;
J Am Coll Cardiol; 2013 Aug; 62(9):789-98. PubMed ID: 23727086
[TBL] [Abstract][Full Text] [Related]
16. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
17. Common variants in the genes of triglyceride and HDL-C metabolism lack association with coronary artery disease in the Pakistani subjects.
Shahid SU; Shabana NA; Cooper JA; Rehman A; Humphries SE
Lipids Health Dis; 2017 Jan; 16(1):24. PubMed ID: 28143480
[TBL] [Abstract][Full Text] [Related]
18. Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects.
Saddi-Rosa P; Oliveira C; Crispim F; Giuffrida FM; de Lima V; Vieira J; Doria A; Velho G; Reis A
Cardiovasc Diabetol; 2013 Aug; 12():119. PubMed ID: 23968400
[TBL] [Abstract][Full Text] [Related]
19. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
20. The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.
Belo VA; Luizon MR; Lacchini R; Miranda JA; Lanna CM; Souza-Costa DC; Tanus-Santos JE
Int J Obes (Lond); 2015 Jan; 39(1):130-5. PubMed ID: 24100423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
